XORTX Therapeutics Inc.
XRTX
$0.64
$0.034.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -649.50K | -717.70K | -698.70K | 122.50K | -587.00K |
| Total Depreciation and Amortization | 29.40K | 27.60K | 26.00K | 26.10K | 25.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.50K | -169.30K | -238.00K | -762.90K | -247.50K |
| Change in Net Operating Assets | 56.00K | 65.80K | 266.90K | -272.20K | 56.70K |
| Cash from Operations | -629.60K | -793.50K | -643.70K | -886.40K | -751.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.50K | -21.80K | -3.40K | -4.00K | -23.20K |
| Cash from Investing | -5.50K | -21.80K | -3.40K | -4.00K | -23.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -21.40K | -23.30K | -23.10K | -22.70K | -22.20K |
| Issuance of Common Stock | 1.04M | 0.00 | 113.50K | 1.50M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -247.20K | -20.20K | -22.80K | -370.30K | 0.00 |
| Cash from Financing | 770.90K | -43.40K | 67.60K | 1.11M | -22.20K |
| Foreign Exchange rate Adjustments | -5.30K | 27.00K | 1.10K | -43.70K | 19.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.40K | -831.80K | -578.40K | 172.90K | -777.70K |